Home » Stocks » HOLX

Hologic, Inc. (HOLX)

Stock Price: $62.99 USD 0.38 (0.61%)
Updated Jun 21, 2021 11:17 AM EDT - Market open
Market Cap 16.04B
Revenue (ttm) 5.32B
Net Income (ttm) 1.91B
Shares Out 258.47M
EPS (ttm) 7.28
PE Ratio 8.65
Forward PE 13.95
Dividend n/a
Dividend Yield n/a
Trading Day June 21
Last Price $62.99
Previous Close $62.61
Change ($) 0.38
Change (%) 0.61%
Day's Open 62.67
Day's Range 62.04 - 63.19
Day's Volume 503,583
52-Week Range 53.02 - 85.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Hologic (HOLX) closed at $62.86 in the latest trading session, marking a +1.57% move from the prior day.

3 days ago - Zacks Investment Research

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #acquisition--Hologic Completes Acquisition of Mobidiag

4 days ago - Business Wire

Hologic (HOLX) closed at $63.39 in the latest trading session, marking a +1.75% move from the prior day.

1 week ago - Zacks Investment Research

Hologic's (HOLX) Acessa procedure new coverage will further validate Laparoscopic Radiofrequency Ablation as a standard of care for uterine fibroids.

Other stocks mentioned: CI
1 week ago - Zacks Investment Research

These businesses are running out of steam. Now may be the time to hit the sell button on their stocks.

Other stocks mentioned: COST, ZM
1 week ago - The Motley Fool

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #Acessa--Cigna Updates Medical Policy to Cover Hologic's Acessa® Procedure, Expanding Access to Millions of Women Across the Country

2 weeks ago - Business Wire

Hologic (HOLX) reported earnings 30 days ago. What's next for the stock?

3 weeks ago - Zacks Investment Research

Hologic's (HOLX) ThinPrep Genesis processor offers new automation capabilities and workflow enhancements.

3 weeks ago - Zacks Investment Research

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #ACOG--New Fibroid Management Guidance from the American College of Obstetricians and Gynecologists Supports Laparoscopic Radiofrequency Ablation

4 weeks ago - Business Wire

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #breastcancer--Medicare Insurance Coverage for Breast Cancer Index™ Test Expanded to Include Node-Positive Breast Cancer

1 month ago - Business Wire

Getting beyond COVID-19 starts with going back to the base business.

1 month ago - The Motley Fool

Investors should hold off permanently rebranding diagnostics stocks as coronavirus stocks, experts say. There's a chance their future could be much brighter despite spreading vaccine use.

Other stocks mentioned: ABT, TMO
1 month ago - Investors Business Daily

The stock price of Hologic (NASDAQ: HOLX), a medical devices company focused on women's health, has seen a large 12% drop in just five trading sessions. The decline was driven primarily due to the compa...

1 month ago - Forbes

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #presentation--Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences

1 month ago - Business Wire

Hologic (HOLX) closed the most recent trading day at $65.92, moving +0.38% from the previous trading session.

1 month ago - Zacks Investment Research

Rebound in base sales make us optimistic about OMI, INGN, XRAY and CNTG's results this time around.

Other stocks mentioned: BSX, CNTG, INGN, LH, OMI, XRAY
1 month ago - Zacks Investment Research

Is (HOLX) Outperforming Other Medical Stocks This Year?

1 month ago - Zacks Investment Research

The three stocks listed below could be of interest to growth-oriented investors, as their price-earnings ratios are below 20 while their trailing 12-month earnings per share increased significantly over...

Other stocks mentioned: CROX, FCNCA
1 month ago - GuruFocus

Hologic (HOLX) exhibited robust segmental growth in second-quarter fiscal 2021, driven by strong performance by the Diagnostics segment amid the coronavirus pandemic.

1 month ago - Zacks Investment Research

Hologic Inc (NASDAQ: HOLX) posted second-quarter results that trailed the consensus forecast; however, the company tried to provide some cushion with a better third-quarter fueled by COVID-19 test reven...

1 month ago - Benzinga

Hologic (HOLX) delivered earnings and revenue surprises of -1.15% and -0.40%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Shares of Hologic (NASDAQ:HOLX) fell in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 354.39% year over year to $2.59, which missed the estimate o...

1 month ago - Benzinga

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #earnings--Hologic Announces Financial Results for Second Quarter of Fiscal 2021

1 month ago - Business Wire

Hologic (HOLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

1 month ago - Zacks Investment Research

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

Other stocks mentioned: ABT, ALGN, BSX, DGX, IART
1 month ago - Zacks Investment Research

Strength in Molecular Diagnostics business is likely to have continued to aid Hologic's (HOLX) performance in the second quarter of fiscal 2021.

1 month ago - Zacks Investment Research

Here we discuss three MedTech subsectors, which encourage us with their consistency through the pandemic year and are likely to have continued with their winning streak in Q121.

Other stocks mentioned: PKI
1 month ago - Zacks Investment Research

Hologic (HOLX) is likely to have gained during fiscal second-quarter 2021 on the back of robust performances of its business arms despite coronavirus-led economic doldrums.

1 month ago - Zacks Investment Research

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

2 months ago - Zacks Investment Research

Hologic (HOLX) closed the most recent trading day at $76.68, moving +0.03% from the previous trading session.

2 months ago - Zacks Investment Research

Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 months ago - Zacks Investment Research

Bell-ringing S&P 500 profit reports are due out starting this week. And you should expect off-the-hook numbers from some companies.

Other stocks mentioned: AIG, AXP, DGX, HBAN, HBI, KEY, PKI ...
2 months ago - Investors Business Daily

Hologic's (HOLX) Mobidiag acquisition will generate long-term value by enabling the company to tap into the global acute care market.

2 months ago - Zacks Investment Research

Let's take a look at the three women healthcare MedTech stocks performing well lately.

Other stocks mentioned: BDX, MYGN
2 months ago - Zacks Investment Research

Flush with cash from its Covid testing business, Hologic Inc. (NASDAQ:HOLX) continued its buying spree, laying out $795 million to add Mobidiag, the private Finnish-French molecular test maker, to the f...

2 months ago - GuruFocus

Hologic Inc (NASDAQ: HOLX) has agreed to acquire Mobidiag Oy, a privately held, Europe-based provider of molecular diagnostic tests and instrumentation, for an enterprise value of approximately $795 mil...

2 months ago - Benzinga

Here we look at three stocks, OMI, HOLX and QGEN, that investors can add to their watchlist backed by robust long-term prospects.

Other stocks mentioned: OMI, QGEN
2 months ago - Zacks Investment Research

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic to Acquire Mobidiag, Innovator in Near-Patient, Acute Care Diagnostic Testing, for Approximately $795 Million

2 months ago - Business Wire

Hologic (HOLX) possesses solid growth attributes, which could help it handily outperform the market.

2 months ago - Zacks Investment Research

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic to Announce Financial Results for the Second Quarter of Fiscal 2021 on Wednesday, April 28, 2021

2 months ago - Business Wire

HOLX vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: SMLR
2 months ago - Zacks Investment Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

2 months ago - Zacks Investment Research

Covid-19 has put healthcare stocks in the limelight. These seven companies should be on your radar for the next pandemic.

Other stocks mentioned: DHR, GERM, GILD, IMVT, PFE, XLV
2 months ago - InvestorPlace

In the latest trading session, Hologic (HOLX) closed at $73.87, marking a -0.44% move from the previous day.

2 months ago - Zacks Investment Research

Is (HOLX) Outperforming Other Medical Stocks This Year?

2 months ago - Zacks Investment Research

3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis

Other stocks mentioned: ABMD, IDXX, ISRG, NTUS, TMO
2 months ago - Zacks Investment Research

Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.

Other stocks mentioned: ABT, CSII, HRC, IDXX, LH, LMAT
2 months ago - Zacks Investment Research

Grab these three top stocks - ABT, HOLX and BIO - that continue to show tremendous promise and stand to benefit from the historic stimulus package.

Other stocks mentioned: ABT, CAH
2 months ago - Zacks Investment Research

In the latest trading session, Hologic (HOLX) closed at $71.98, marking a -1.03% move from the previous day.

2 months ago - Zacks Investment Research

Investors remain optimistic about Hologic (HOLX) on its strong molecular diagnostic growth and robust international performance.

2 months ago - Zacks Investment Research

About HOLX

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fus... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Jun 21, 1990
CEO
Stephen MacMillan
Employees
5,814
Stock Exchange
NASDAQ
Ticker Symbol
HOLX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 16 analysts, the average rating for Hologic stock is "Buy." The 12-month stock price forecast is 82.92, which is an increase of 31.64% from the latest price.

Price Target
$82.92
(31.64% upside)
Analyst Consensus: Buy